FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2767346039> ?p ?o ?g. }

• W2767346039 endingPage "737" @default.
• W2767346039 startingPage "729" @default.
• W2767346039 abstract "Abstract This clinical trial developed a personalized dosing model for reducing prostaglandin E2 (PGE2) in colonic mucosa using ω-3 fatty acid supplementation. The model utilized serum eicosapentaenoic acid (EPA, ω-3):arachidonic acid (AA, ω-6) ratios as biomarkers of colonic mucosal PGE2 concentration. Normal human volunteers were given low and high ω-3 fatty acid test doses for 2 weeks. This established a slope and intercept of the line for dose versus serum EPA:AA ratio in each individual. The slope and intercept was utilized to calculate a personalized target dose that was given for 12 weeks. This target dose was calculated on the basis of a model, initially derived from lean rodents, showing a log-linear relationship between serum EPA:AA ratios and colonic mucosal PGE2 reduction. Bayesian methods allowed addition of human data to the rodent model as the trial progressed. The dosing model aimed to achieve a serum EPA:AA ratio that is associated with a 50% reduction in colonic PGE2. Mean colonic mucosal PGE2 concentrations were 6.55 ng/mg protein (SD, 5.78) before any supplementation and 3.59 ng/mg protein (SD, 3.29) after 12 weeks of target dosing. In secondary analyses, the decreases in PGE2 were significantly attenuated in overweight and obese participants. This occurred despite a higher target dose for the obese versus normal weight participants, as generated by the pharmacodynamic predictive model. Large decreases also were observed in 12-hydroxyicosatetraenoic acids, and PGE3 increased substantially. Future biomarker-driven dosing models for cancer prevention therefore should consider energy balance as well as overall eicosanoid homeostasis in normal tissue. Cancer Prev Res; 10(12); 729–37. ©2017 AACR." @default.
• W2767346039 created "2017-11-17" @default.
• W2767346039 creator A5000119502 @default.
• W2767346039 creator A5018151038 @default.
• W2767346039 creator A5019182441 @default.
• W2767346039 creator A5025677580 @default.
• W2767346039 creator A5026467316 @default.
• W2767346039 creator A5038842237 @default.
• W2767346039 creator A5055932789 @default.
• W2767346039 creator A5056886978 @default.
• W2767346039 creator A5059865920 @default.
• W2767346039 creator A5073466977 @default.
• W2767346039 creator A5086113297 @default.
• W2767346039 date "2017-12-01" @default.
• W2767346039 modified "2023-10-15" @default.
• W2767346039 title "The Anti-inflammatory Effect of Personalized Omega-3 Fatty Acid Dosing for Reducing Prostaglandin E2 in the Colonic Mucosa Is Attenuated in Obesity" @default.
• W2767346039 cites W1966594595 @default.
• W2767346039 cites W1973205844 @default.
• W2767346039 cites W1979723442 @default.
• W2767346039 cites W1988999006 @default.
• W2767346039 cites W1989333956 @default.
• W2767346039 cites W2000854747 @default.
• W2767346039 cites W2007253276 @default.
• W2767346039 cites W2007869047 @default.
• W2767346039 cites W2011325999 @default.
• W2767346039 cites W2012608972 @default.
• W2767346039 cites W2013751342 @default.
• W2767346039 cites W2015027552 @default.
• W2767346039 cites W2025451005 @default.
• W2767346039 cites W2031077831 @default.
• W2767346039 cites W2032044380 @default.
• W2767346039 cites W2035096004 @default.
• W2767346039 cites W2036948641 @default.
• W2767346039 cites W2037115363 @default.
• W2767346039 cites W2038751421 @default.
• W2767346039 cites W2046950425 @default.
• W2767346039 cites W2047319374 @default.
• W2767346039 cites W2057605095 @default.
• W2767346039 cites W2061398650 @default.
• W2767346039 cites W2064152633 @default.
• W2767346039 cites W2078378773 @default.
• W2767346039 cites W2080289362 @default.
• W2767346039 cites W2080840899 @default.
• W2767346039 cites W2081577661 @default.
• W2767346039 cites W2082253391 @default.
• W2767346039 cites W2084647545 @default.
• W2767346039 cites W2085952779 @default.
• W2767346039 cites W2098392939 @default.
• W2767346039 cites W2101841000 @default.
• W2767346039 cites W2108514581 @default.
• W2767346039 cites W2118937976 @default.
• W2767346039 cites W2123742998 @default.
• W2767346039 cites W2125884465 @default.
• W2767346039 cites W2136611420 @default.
• W2767346039 cites W2147855987 @default.
• W2767346039 cites W2151495986 @default.
• W2767346039 cites W2156061283 @default.
• W2767346039 cites W2157204944 @default.
• W2767346039 cites W2216643141 @default.
• W2767346039 cites W2275838662 @default.
• W2767346039 cites W2425295107 @default.
• W2767346039 cites W2583218221 @default.
• W2767346039 cites W2592578600 @default.
• W2767346039 cites W4557704 @default.
• W2767346039 doi "https://doi.org/10.1158/1940-6207.capr-17-0091" @default.
• W2767346039 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5767924" @default.
• W2767346039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29133307" @default.
• W2767346039 hasPublicationYear "2017" @default.
• W2767346039 type Work @default.
• W2767346039 sameAs 2767346039 @default.
• W2767346039 citedByCount "15" @default.
• W2767346039 countsByYear W27673460392017 @default.
• W2767346039 countsByYear W27673460392018 @default.
• W2767346039 countsByYear W27673460392019 @default.
• W2767346039 countsByYear W27673460392020 @default.
• W2767346039 countsByYear W27673460392021 @default.
• W2767346039 countsByYear W27673460392022 @default.
• W2767346039 countsByYear W27673460392023 @default.
• W2767346039 crossrefType "journal-article" @default.
• W2767346039 hasAuthorship W2767346039A5000119502 @default.
• W2767346039 hasAuthorship W2767346039A5018151038 @default.
• W2767346039 hasAuthorship W2767346039A5019182441 @default.
• W2767346039 hasAuthorship W2767346039A5025677580 @default.
• W2767346039 hasAuthorship W2767346039A5026467316 @default.
• W2767346039 hasAuthorship W2767346039A5038842237 @default.
• W2767346039 hasAuthorship W2767346039A5055932789 @default.
• W2767346039 hasAuthorship W2767346039A5056886978 @default.
• W2767346039 hasAuthorship W2767346039A5059865920 @default.
• W2767346039 hasAuthorship W2767346039A5073466977 @default.
• W2767346039 hasAuthorship W2767346039A5086113297 @default.
• W2767346039 hasBestOaLocation W27673460391 @default.
• W2767346039 hasConcept C111113717 @default.
• W2767346039 hasConcept C112705442 @default.
• W2767346039 hasConcept C126322002 @default.
• W2767346039 hasConcept C134018914 @default.
• W2767346039 hasConcept C181199279 @default.
• W2767346039 hasConcept C185592680 @default.
• W2767346039 hasConcept C19038510 @default.

• next